Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Penicillins	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Back	O
pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None.	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
yo	O
woman	O
with	O
h/o	O
CAD	O
s/p	O
DES	O
to	O
LAD	O
on	O
___,	O
HFpEF,	O
hypertension,	O
hypothyroidism,	O
CKD,	O
bilateral	O
carotid	O
artery	O
stenosis,	O
osteoporosis,	O
paroxysmal	O
afib	O
(no	O
longer	O
on	O
warfarin),	O
anemia,	O
and	O
recent	O
upper	B-Upper_gastrointestinal_haemorrhage
GI	B-Upper_gastrointestinal_haemorrhage
bleed,	B-Upper_gastrointestinal_haemorrhage
who	O
presents	O
with	O
bilateral	O
back/flank	O
pain	O
for	O
the	O
past	O
week.	O
Per	O
ED,	O
patient	O
complained	O
of	O
decreased	O
PO	O
intake,	O
intermittent	O
fevers	O
and	O
chills	O
over	O
the	O
past	O
week,	O
as	O
well	O
as	O
bilateral	O
lower	O
back	O
pain.	O
Per	O
patient,	O
she	O
has	O
not	O
had	O
any	O
fevers	O
or	O
chills.	O
She	O
says	O
the	O
pain	O
is	O
worse	O
with	O
movement.	O
She	O
denies	O
any	O
recent	O
change	O
in	O
appetite,	O
though	O
admits	O
that	O
her	O
son	O
thinks	O
she	O
does	O
not	O
eat	O
very	O
much	O
and	O
is	O
too	B-Weight_loss
skinny.	B-Weight_loss
She	O
says	O
her	O
appetite	O
was	O
decreased	O
after	O
her	O
husband	B-Lives_alone
died	B-Lives_alone
in	O
___.	O
Of	O
note,	O
patient	O
recently	O
admitted	O
to	O
OSH	O
for	O
upper	B-Upper_gastrointestinal_haemorrhage
GI	B-Upper_gastrointestinal_haemorrhage
bleed	B-Upper_gastrointestinal_haemorrhage
requiring	O
1	O
unit	O
PRBCs.	O
Was	O
discharged	O
off	O
warfarin	O
and	O
is	O
supposed	O
to	O
have	O
GI	O
follow	O
up.	O
She	O
denies	O
any	O
known	O
bleeding	B-Upper_gastrointestinal_haemorrhage
since	O
that	O
time.	O
Patient	O
was	O
also	O
seen	O
recently	O
by	O
PCP	O
for	O
low	O
back	O
pain	O
and	O
was	O
started	O
on	O
tramadol	O
at	O
that	O
time	O
for	O
presumed	O
musculoskeletal	O
pain.	O
Comprehensive	O
10-point	O
review	O
of	O
systems	O
is	O
otherwise	O
negative.	O
ED	O
course:	O
-	O
Vitals:	O
Afebrile,	O
HR	O
___,	O
BP	O
140s-170s/30s-80s	O
-	O
Exam:	O
Guaiac	O
positive	O
brown	O
stool	O
-	O
Labs:	O
WBC	O
19.8,	O
UA	O
___	O
72WBC	O
few	O
bact,	O
troponin	O
<0.01.	O
-	O
Imaging:	O
CXR	O
-	O
COPD,	O
no	O
PNA.	B-Lower_respiratory_tract_infection
-	O
Meds:	O
Vancomycin	O
1g	O
IV,	O
cefepime	O
2g	O
IV,	O
1L	O
NS	O
-	O
Plan:	O
Given	O
vanc/cefepime	O
"given	O
recent	O
abx	O
dose,	O
inpatient	O
hospitalization"	O
Past	O
Medical	O
History:	O
CAD	O
s/p	O
DES	O
to	O
LAD	O
on	O
___	O
MI	O
with	O
PCI	O
___	O
years	O
ago	O
at	O
___	O
according	O
to	O
___	O
cardiology	O
note	O
CKD	O
Anemia	O
Bilateral	O
carotid	O
artery	O
stenosis	O
Osteoporosis	O
Vitamin	O
D	O
deficiency	O
Hypertension	O
Atrial	O
Fibrillation	O
(RVR	O
in	O
___	O
not	O
anticoagulated)	O
HFpEF	O
(65%	O
on	O
TTE	O
___	O
Hypothyroidism	O
(post-surgical)	O
Upper	B-Upper_gastrointestinal_haemorrhage
GI	B-Upper_gastrointestinal_haemorrhage
bleeding	B-Upper_gastrointestinal_haemorrhage
Social	O
History:	O
___	O
Family	O
History:	O
No	O
family	O
history	O
of	O
early	O
MI,	O
arrhythmia,	O
cardiomyopathies,	O
or	O
sudden	O
cardiac	O
death.	O
Physical	O
Exam:	O
ADMISSION	O
EXAM:	O
Vital	O
signs:	O
T	O
97.7,	O
BP	O
160/60,	O
P	O
67,	O
RR	O
18,	O
O2	O
94%	O
RA	O
Gen:	O
Cachectic	B-Malnutrition
appearing,	O
no	O
acute	O
distress	O
HEENT:	O
NCAT,	O
oropharynx	O
clear	O
Lymph:	O
no	O
cervical	O
lymphadenopathy	O
CV:	O
No	O
JVD	O
present,	O
bradycardic,	O
irregular,	O
no	O
murmurs	O
appreciated	O
Resp:	O
CTA	O
bilaterally	O
in	O
anterior	O
and	O
posterior	O
lung	O
fields,	O
no	O
increased	O
work	O
of	O
breathing	O
GI:	O
soft,	O
non-tender,	O
non-distended.	O
No	O
hepatosplenomegaly	O
appreciated.	O
Back:	O
+CVA	O
tenderness	O
GU:	O
No	O
suprapubic	O
tenderness	O
Extremities:	O
Mottling	O
diffusely	O
on	O
bilateral	O
lower	O
extremities,	O
no	O
___	O
edema,	O
warm,	O
1+	O
distal	O
pulses	O
Neuro:	O
no	O
focal	O
neurologic	O
deficits	O
appreciated.	O
Moves	O
all	O
4	O
extremities	O
purposefully	O
and	O
without	O
incident,	O
no	O
facial	O
droop.	O
Psych:	O
Euthymic,	O
speech	O
non-tangential,	O
appropriate	O
.	O
.	O
DISCHARGE	O
EXAM:	O
Vital	O
signs:	O
T	O
97.7	O
PO	O
BP	O
166	O
/	O
62	O
HR	O
82	O
RR	O
18	O
95%	O
RA	O
Weight:	O
recorded	O
as	O
38	O
kg	O
(standing	O
weight)	O
Gen:	O
Cachectic	B-Malnutrition
appearing,	O
appears	O
comfortable	O
sitting	O
up	O
in	O
bed	O
HEENT:	O
oropharynx	O
clear,	O
MMM,	O
EOMI	O
CV:	O
No	O
JVD	O
present,	O
irregular,	O
no	O
murmurs	O
appreciated	O
Resp:	O
bibasilar	O
crackles,	O
otherwise	O
CTAB	O
with	O
normal	O
WOB	O
GI:	O
thin	O
habitus,	O
soft,	O
non-tender,	O
non-distended,	O
BS+	O
Back:	O
+CVA	O
tenderness	O
bilaterally,	O
but	O
this	O
is	O
notably	O
tenderness	O
to	O
very	O
minimal	O
palpation	O
(c/w	O
allodynia)	O
and	O
is	O
fairly	O
equal	O
on	O
both	O
sides;	O
no	O
overlying	O
skin	O
changes/rash/erythema;	O
no	O
spinous	O
process	O
tenderness;	O
+	O
scoliosis	O
GU:	O
No	O
suprapubic	O
tenderness	O
Extremities:	O
very	O
thin,	O
no	O
___	O
edema,	O
warm,	O
1+	O
distal	O
pulses	O
Neuro:	O
no	O
focal	O
neurologic	O
deficits	O
appreciated.	O
Moves	O
all	O
4	O
extremities	O
purposefully,	O
no	O
facial	O
droop,	O
conversant	O
with	O
clear	O
speech	O
Psych:	O
calm,	O
cooperative	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
___	O
06:45PM	O
BLOOD	O
WBC-19.8*#	O
RBC-3.14*	O
Hgb-9.4*	O
Hct-30.5*	O
MCV-97	O
MCH-29.9	O
MCHC-30.8*	O
RDW-14.9	O
RDWSD-53.4*	O
Plt	O
___	O
___	O
06:45PM	O
BLOOD	O
Neuts-83.7*	O
Lymphs-8.7*	O
Monos-6.6	O
Eos-0.1*	O
Baso-0.2	O
Im	O
___	O
AbsNeut-16.60*	O
AbsLymp-1.72	O
AbsMono-1.30*	O
AbsEos-0.01*	O
AbsBaso-0.04	O
___	O
09:05PM	O
BLOOD	O
___	O
PTT-29.9	O
___	O
___	O
06:45PM	O
BLOOD	O
Glucose-94	O
UreaN-21*	O
Creat-1.3*	O
Na-143	O
K-3.3	O
Cl-105	O
HCO3-15*	O
AnGap-26*	O
___	O
06:45PM	O
BLOOD	O
cTropnT-<0.01	O
___	O
06:45PM	O
BLOOD	O
Calcium-8.9	O
Phos-4.5	O
Mg-1.7	O
___	O
06:45PM	O
BLOOD	O
Osmolal-302	O
___	O
09:08PM	O
BLOOD	O
Lactate-2.0	O
.	O
DISCHARGE	O
LABS:	O
___	O
10:45AM	O
BLOOD	O
WBC-13.7*	O
RBC-2.95*	O
Hgb-8.9*	O
Hct-29.0*	O
MCV-98	O
MCH-30.2	O
MCHC-30.7*	O
RDW-15.1	O
RDWSD-53.9*	O
Plt	O
___	O
___	O
10:45AM	O
BLOOD	O
Neuts-70.3	O
___	O
Monos-5.8	O
Eos-2.0	O
Baso-0.4	O
Im	O
___	O
AbsNeut-9.63*	O
AbsLymp-2.84	O
AbsMono-0.80	O
AbsEos-0.28	O
AbsBaso-0.05	O
___	O
06:30AM	O
BLOOD	O
Glucose-81	O
UreaN-26*	O
Creat-1.1	O
Na-143	O
K-4.2	O
Cl-109*	O
HCO3-18*	O
AnGap-20	O
___	O
10:45AM	O
BLOOD	O
CK(CPK)-25*	O
___	O
06:30AM	O
BLOOD	O
Calcium-8.9	O
Phos-3.5	O
Mg-1.8	O
.	O
Micro:	O
-___	O
UCx:(Final	O
___:	O
MIXED	O
BACTERIAL	O
FLORA	O
(	O
>=	O
3	O
COLONY	O
TYPES),	O
CONSISTENT	O
WITH	O
SKIN	O
AND/OR	O
GENITAL	O
CONTAMINATION.	O
ENTEROCOCCUS	O
SP..	O
>100,000	O
CFU/mL.	O
PREDOMINATING	O
ORGANISM	O
INTERPRET	O
RESULTS	O
WITH	O
CAUTION.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
ENTEROCOCCUS	O
SP.	O
|	O
AMPICILLIN------------	O
<=2	O
S	O
NITROFURANTOIN--------	O
<=16	O
S	O
TETRACYCLINE----------	O
<=1	O
S	O
VANCOMYCIN------------	O
1	O
S	O
.	O
.	O
-___	O
BCx:	O
NGTD	O
-___	O
BCx:	O
NGTD	O
.	O
IMAGING:	O
___	O
CXR	O
-	O
hyperinflated	O
lungs,	O
no	O
PNA.	B-Lower_respiratory_tract_infection
Brief	O
Hospital	O
Course:	O
Ms.	O
___	O
is	O
a	O
___	O
yo	O
woman	O
with	O
h/o	O
CAD	O
s/p	O
DES	O
to	O
LAD	O
on	O
___,	O
HFpEF,	O
hypertension,	O
hypothyroidism,	O
CKD,	O
bilateral	O
carotid	O
artery	O
stenosis,	O
osteoporosis,	O
paroxysmal	O
afib	O
(no	O
longer	O
on	O
warfarin),	O
anemia,	O
and	O
recent	O
upper	B-Upper_gastrointestinal_haemorrhage
GI	B-Upper_gastrointestinal_haemorrhage
bleed,	B-Upper_gastrointestinal_haemorrhage
who	O
presents	O
with	O
bilateral	O
back/flank	O
pain	O
for	O
the	O
past	O
week.	O
.	O
#	O
URINARY	B-Urinary_tract_infection
TRACT	B-Urinary_tract_infection
INFECTION:	B-Urinary_tract_infection
UA	O
positive	O
and	O
good	O
sample.	O
She	O
had	O
significant	O
leukocytosis	O
on	O
presentation.	O
Per	O
ED	O
HPI	O
patient	O
has	O
had	O
fevers,	O
but	O
patient	O
herself	O
adamantly	O
denies	O
this	O
and	O
she	O
has	O
had	O
no	O
fevers	O
here.	O
No	O
other	O
likely	O
sources	O
of	O
infection	O
were	O
identified.	O
UCx	O
ultimately	O
grew	O
MBF	O
+	O
predominant	O
organism	O
of	O
enterococcus	O
sp.	O
which	O
was	O
pan-S.	O
She	O
improved	O
clinically	O
(improving	O
WBC,	O
improving	O
low-back	O
pain)	O
with	O
treatment	O
with	O
ceftriaxone.	O
She	O
received	O
a	O
total	O
of	O
4	O
days	O
of	O
IV	O
abx	O
(IV	O
vanc/cefepime	O
in	O
ED	O
on	O
___,	O
IV	O
CTX	O
on	O
___.	O
Once	O
culture	O
results	O
returned	O
pan-S	O
enterococcus	O
sp.,	O
we	O
discussed	O
with	O
the	O
___	O
Stewardship	O
Team	O
(AST)	O
re:	O
optimal	O
PO	O
abx	O
regimen	O
for	O
her	O
given	O
penicillin	O
allergy	O
and	O
improvement	O
on	O
CTX,	O
which	O
theoretically	O
does	O
not	O
cover	O
enterococcus.	O
They	O
advised	O
that	O
macrobid,	O
fosfomycin,	O
and	O
cefpodoxime	O
were	O
all	O
potentially	O
reasonable	O
choices,	O
and	O
advised	O
a	O
slightly	O
prolonged	O
course	O
given	O
the	O
degree	O
of	O
her	O
leukocytosis	O
and	O
?	O
of	O
pyelonephritis.	O
Given	O
low	O
overall	O
suspicion	O
for	O
pyelo,	O
since	O
her	O
physical	O
exam	O
did	O
not	O
change	O
significantly	O
as	O
she	O
clinically	O
improved,	O
we	O
went	O
with	O
macrobid	O
for	O
a	O
total	O
of	O
6	O
additional	O
days	O
to	O
complete	O
10	O
total	O
days	O
of	O
abx.	O
Advised	O
patient	O
re:	O
what	O
signs/symptoms	O
would	O
warrant	O
her	O
seeking	O
medical	O
attention	O
(fevers,	O
shaking	O
chills,	O
increasing	O
flank	O
pain,	O
dysuria,	O
or	O
other	O
concerning	O
symptoms).	O
On	O
the	O
day	O
of	O
discharge	O
she	O
said	O
she	O
felt	O
well,	O
was	O
having	O
pain	O
consistent	O
with	O
her	O
chronic	O
pain,	O
and	O
felt	O
comfortable	O
going	O
home.	O
.	O
#	O
Acute	O
on	O
chronic	O
lower	O
back	O
pain:	O
initially	O
patient	O
reported	O
that	O
pain	O
was	O
just	O
1	O
week	O
in	O
duration.	O
Later	O
she	O
informed	O
us	O
that	O
lower	O
back	O
pain	O
has	O
been	O
a	O
chronic	O
issue,	O
but	O
was	O
acutely	O
worse	O
over	O
past	O
week.	O
Exam	O
revealed	O
allodynia.	O
Treated	O
with	O
Tylenol,	O
lidocaine	O
patch,	O
and	O
tramadol	O
PRN.	O
Gradually	O
improved.	O
She	O
worked	O
with	O
___,	O
who	O
found	O
her	O
to	O
be	O
at	O
her	O
approximate	O
baseline	O
level	O
of	O
pain	O
and	O
mobility.	O
.	O
#	O
FAILURE	O
TO	O
THRIVE:	O
Patient	O
reportedly	O
is	O
not	O
doing	O
well	O
caring	O
for	O
herself	O
at	O
home.	O
Per	O
outpatient	O
records	O
she	O
has	O
not	O
allowed	O
___	O
to	O
come	O
to	O
her	O
home	O
and	O
has	O
also	O
had	O
very	O
poor	B-Malnutrition
nutrition.	B-Malnutrition
There	O
might	O
also	O
be	O
a	O
significant	O
psychiatric	O
component.	O
Nutrition	O
recs:	O
Ensure	O
TID,	O
MVI	O
w/	O
minerals.	O
___	O
recs:	O
she	O
is	O
approximately	O
at	O
her	O
baseline,	O
mobilizes	O
with	O
rolling	O
walker.	B-Mobile_with_aid
Patient	O
declined	O
___	O
services	B-Has_carers
at	O
home.	O
SW	O
consulted	O
and	O
offered	O
services,	B-Has_carers
but	O
patient	O
declined.	O
We	O
think	O
she	O
will	O
benefit	O
from	O
treatment	O
for	O
depression	O
and	O
continued	O
offers	O
of	O
additional	O
assistance/home	I-Has_carers
support	B-Has_carers
from	O
her	O
primary	O
providers	O
going	O
forward.	O
.	O
#	O
DEPRESSION:	O
unclear	O
if	O
new	O
onset	O
MDD	O
vs.	O
recurrent	O
based	O
on	O
history.	O
Psych	O
consulted	O
given	O
the	O
concurrence	O
of	O
her	O
apparent	O
depression	O
with	O
failure	O
to	O
thrive	O
at	O
home.	O
They	O
recommended	O
starting	O
mirtazapine	O
7.5	O
mg	O
PO	O
QHS	O
x2	O
nights,	O
then	O
increasing	O
to	O
15	O
mg	O
PO	O
QHS.	O
She	O
tolerated	O
the	O
first	O
dose	O
of	O
mirtazapine	O
without	O
issue	O
on	O
___	O
and	O
was	O
agreeable	O
to	O
continuing	O
this	O
medication.	O
She	O
should	O
have	O
f/u	O
eval/tx	O
for	O
depression	O
going	O
forward.	O
She	O
said	O
she	O
was	O
definitely	O
willing	O
to	O
follow-up	O
with	O
her	O
PCP	O
___:	O
depression,	O
but	O
was	O
not	O
as	O
sure	O
about	O
her	O
willingness	O
to	O
establish	O
care	O
with	O
a	O
psychiatrist.	O
.	O
#	O
CAD	O
s/p	O
DES	O
TO	O
LAD:	O
Given	O
recent	O
DES	O
to	O
LAD	O
will	O
require	O
continued	O
DAPT	O
with	O
ASA/Plavix	O
even	O
if	O
bleeding.	O
Continued	O
ASA,	O
Plavix.	O
Continued	O
atorvastatin,	O
metoprolol.	O
.	O
#	O
ANEMIA:	O
stable,	O
no	O
evidence	O
of	O
clinically	O
significant	O
bleeding	O
on	O
dual	O
anti-platelet	O
therapy.	O
.	O
#	O
GERD,	O
RECENT	O
UPPER	B-Upper_gastrointestinal_haemorrhage
GI	B-Upper_gastrointestinal_haemorrhage
BLEED:	B-Upper_gastrointestinal_haemorrhage
Recent	O
hospitalization	O
for	O
presumed	O
upper	O
GI	O
bleed	O
requiring	O
1u	O
PRBC.	O
Was	O
supposed	O
to	O
have	O
outpatient	O
GI	O
f/u	O
with	O
EGD.	O
Continued	O
pantoprazole.	O
-	O
Hgb	O
has	O
been	O
stable	O
on	O
her	O
home	O
anti-platelet	O
regimen,	O
will	O
defer	O
additional	O
w/u	O
for	O
GIB	O
to	O
outpatient	O
GI.	O
Has	O
f/u	O
scheduled	O
on	O
___.	O
.	O
#	O
ATRIAL	O
FIBRILLATION:	O
Was	O
initially	O
bradycardic,	O
now	O
resolved.	O
Metoprolol	O
dose	O
was	O
decreased	O
during	O
recent	O
hospitalization,	O
presumably	O
for	O
bradycardia.	O
Not	O
on	O
warfarin	O
due	O
to	O
bleeding	O
risk/hx	O
of	O
bleeding.	O
Continued	O
metoprolol	O
25mg	O
XL.	O
.	O
#	O
HYPERTENSION:	O
Amlodipine	O
recently	O
stopped,	O
but	O
unclear	O
reason.	O
Has	O
been	O
mildly	O
hypertensive	O
at	O
times	O
during	O
hospitalization.	O
Continued	O
home	O
metoprolol,	O
no	O
additional	O
agents	O
added	O
to	O
her	O
regimen.	O
.	O
#	O
HYPOTHYROIDISM:	O
continued	O
levothyroxine.	O
.	O
.	O
Time	O
in	O
care:	O
45	O
minutes	O
in	O
patient	O
care,	O
patient	O
counseling,	O
and	O
care	O
coordination	O
on	O
the	O
day	O
of	O
discharge.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
2.	O
Cyanocobalamin	O
1000	O
mcg	O
PO	O
DAILY	O
3.	O
Levothyroxine	O
Sodium	O
100	O
mcg	O
PO	O
DAILY	O
4.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
5.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
6.	O
Acetaminophen	O
500	O
mg	O
PO	O
Q8H:PRN	O
pain	O
7.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
8.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
9.	O
Vitamin	O
D	O
___	O
UNIT	O
PO	O
DAILY	O
10.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
DAILY	O
11.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
Discharge	O
Medications:	O
1.	O
Mirtazapine	O
15	O
mg	O
PO	O
QHS	O
RX	O
*mirtazapine	O
15	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
at	O
bedtime	O
Disp	O
#*30	O
Tablet	O
Refills:*3	O
2.	O
Multivitamins	O
W/minerals	O
1	O
TAB	O
PO	O
DAILY	O
RX	O
*multivitamin,tx-minerals	O
[Vitamins	O
and	O
Minerals]	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*3	O
3.	O
Nitrofurantoin	O
Monohyd	O
(MacroBID)	O
100	O
mg	O
PO	O
Q12H	O
Duration:	O
6	O
Days	O
last	O
dose	O
on	O
___	O
RX	O
*nitrofurantoin	O
monohyd/m-cryst	O
100	O
mg	O
1	O
capsule(s)	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*12	O
Capsule	O
Refills:*0	O
4.	O
Acetaminophen	O
500	O
mg	O
PO	O
Q8H:PRN	O
pain	O
5.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
6.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
7.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
8.	O
Cyanocobalamin	O
1000	O
mcg	O
PO	O
DAILY	O
9.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
DAILY	O
10.	O
Levothyroxine	O
Sodium	O
100	O
mcg	O
PO	O
DAILY	O
11.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
12.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
13.	O
Vitamin	O
D	O
___	O
UNIT	O
PO	O
DAILY	O
14.Rolling	O
walker	B-Mobile_with_aid
Dx:	O
Gait	O
instability,	O
CAD,	O
CHF,	O
Osteoporosis	O
Progrnosis:	O
good	O
Length	O
of	O
need:	O
13	O
months	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection	B-Urinary_tract_infection
Depression	O
Acute	O
on	O
chronic	O
lower	O
back	O
pain	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_aid
-	O
requires	O
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Ms	O
___,	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
with	O
worsening	O
back	O
pain	O
and	O
reported	O
fevers	O
and	O
were	O
found	O
to	O
have	O
elevated	O
inflammatory	O
markers	O
and	O
a	O
urinalysis	O
suggestive	O
of	O
a	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection.	B-Urinary_tract_infection
Your	O
urine	O
culture	O
ultimately	O
grew	O
multiple	O
bacteria,	O
with	O
one	O
predominant.	O
You	O
were	O
treated	O
with	O
IV	O
antibiotics	O
and	O
improved,	O
and	O
on	O
the	O
day	O
of	O
discharge	O
you	O
were	O
transitioned	O
to	O
an	O
oral	O
antibiotic	O
(Macrobid)	O
based	O
on	O
the	O
urine	O
culture	O
results.	O
You	O
were	O
also	O
evaluated	O
by	O
the	O
Psychiatry	O
team	O
based	O
on	O
our	O
concern	O
for,	O
and	O
your	O
report	O
of,	O
significant	O
depression.	O
You	O
were	O
started	O
on	O
a	O
new	O
medication	O
(Mirtazapine)	O
for	O
treatment	O
of	O
depression.	O
We	O
do	O
not	O
expect	O
an	O
immediate	O
change	O
in	O
how	O
you	O
feel	O
with	O
this	O
medication,	O
but	O
are	O
hopeful	O
that	O
it	O
will	O
help	O
your	O
depression	O
over	O
the	O
coming	O
days	O
to	O
weeks.	O
It	O
will	O
be	O
important	O
that	O
you	O
follow-up	O
with	O
your	O
primary	O
care	O
physician	O
regarding	O
your	O
depression.	O
It	O
was	O
a	O
pleasure	O
caring	O
for	O
you	O
while	O
you	O
were	O
in	O
the	O
hospital,	O
and	O
we	O
wish	O
you	O
a	O
full	O
and	O
speedy	O
recovery.	O
Sincerely,	O
The	O
___	O
Medicine	O
Team	O
Followup	O
Instructions:	O
___	O

